Lin Yi-Yu, Chen Yi-Jung, Hsu Chih-Po, Huang Jen-Fu, Lin Ya-Chiao, Kuo Ling-Wei, Cheng Chi-Tung, Liao Chien-Hung
Division of Thoracic and Cardiovascular Surgery, Department of Surgery, Jen-Ai Hospital, Dali Branch, Taichung, Taiwan.
Kinmen Hospital, Ministry of Health and Welfare, Kinmen, Taiwan.
World J Emerg Surg. 2025 Jul 10;20(1):61. doi: 10.1186/s13017-025-00634-2.
Rib fractures are frequently encountered in trauma care and are particularly hazardous for functionally dependent patients, leading to increased morbidity and mortality rates. Surgical stabilization of rib fractures (SSRF) improves outcomes in selected populations; however, its role in functionally dependent individuals remains underexplored.
A retrospective cohort analysis was conducted using the American College of Surgeons-Trauma Quality Improvement Program dataset from 2020 to 2022. Patients with three or more rib fractures and AIS (Abbreviated Injury Scale) greater than 3 for the rib and thoracic wall, along with documented functional dependency, were included. Propensity score matching (3:1) was applied to reduce the selection bias between patients receiving SSRF and those managed conservatively. The main outcomes of interest were in-hospital mortality, acute respiratory distress syndrome, unplanned intensive care unit (ICU) admission, unplanned intubation, and ventilator-associated pneumonia (VAP). A subgroup analysis compared early (≤ 72 h) versus late SSRF.
Among 18,643 eligible patients, 359 (1.9%) underwent SSRF. Before matching, patients with SSRF had higher Injury Severity Scores (ISS), ICU admissions, and complication rates. After matching (294 SSRF vs. 883 conservative patients), SSRF was associated with significantly lower mortality (4.8% vs. 8.7%, p = 0.038) despite higher rates of unplanned ICU admission (11.2% vs. 7.0%, p = 0.031), unplanned intubation (10.2% vs. 6.1%, p = 0.026), and VAP (3.1% vs. 0.6%, p = 0.002). In the subgroup analysis, early SSRF led to fewer ventilator days (p = 0.013), and shorter ICU (p < 0.001), and hospital length of stays (LOS, p < 0.001), with no difference in mortality compared with late SSRF. However, the late SSRF group still had significantly lower in-hospital mortality compared to the conservative treatment group (3.8% vs. 10.9%, p = 0.023).
SSRF in functionally dependent trauma patients with multiple rib fractures and significant chest wall injury (AIS ≥ 3) is associated with a significant reduction in in-hospital mortality compared to conservative management, despite a higher incidence of complications and prolonged ICU LOS. Early SSRF further improves clinical outcomes by decreasing ventilator duration and overall hospital LOS. These findings support the consideration of SSRF-particularly when performed early-as a beneficial strategy for managing rib fractures in functionally dependent patients. Even when performed at a later stage, SSRF still offers advantages over conservative treatment in reducing mortality. prospective studies are warranted to validate these results and establish clear patient selection criteria.
肋骨骨折在创伤治疗中很常见,对功能依赖患者尤其危险,会导致发病率和死亡率增加。肋骨骨折的手术固定(SSRF)可改善特定人群的治疗效果;然而,其在功能依赖个体中的作用仍未得到充分研究。
使用美国外科医师学会创伤质量改进计划2020年至2022年的数据集进行回顾性队列分析。纳入肋骨骨折三根及以上、肋骨和胸壁的简明损伤分级(AIS)大于3且有功能依赖记录的患者。采用倾向评分匹配(3:1)以减少接受SSRF治疗的患者与保守治疗患者之间的选择偏倚。主要关注的结局指标为住院死亡率、急性呼吸窘迫综合征、非计划重症监护病房(ICU)入院、非计划插管和呼吸机相关性肺炎(VAP)。亚组分析比较了早期(≤72小时)与晚期SSRF。
在18643例符合条件的患者中,359例(1.9%)接受了SSRF。匹配前,接受SSRF的患者损伤严重程度评分(ISS)、ICU入院率和并发症发生率更高。匹配后(294例接受SSRF治疗的患者与883例保守治疗患者),尽管非计划ICU入院率(11.2%对7.0%,p = 0.031)、非计划插管率(10.2%对6.1%,p = 0.026)和VAP发生率(3.1%对0.6%,p = 0.002)较高,但SSRF与显著降低的死亡率相关(4.8%对8.7%,p = 0.038)。在亚组分析中,早期SSRF导致呼吸机使用天数减少(p = 0.013),ICU住院时间缩短(p < 0.001),住院时间缩短(LOS,p < 0.001),与晚期SSRF相比死亡率无差异。然而,晚期SSRF组的住院死亡率仍显著低于保守治疗组(3.8%对10.9%,p = 0.023)。
对于有多处肋骨骨折和严重胸壁损伤(AIS≥3)的功能依赖创伤患者,与保守治疗相比,SSRF可显著降低住院死亡率,尽管并发症发生率较高且ICU住院时间延长。早期SSRF通过减少呼吸机使用时间和缩短总体住院时间进一步改善临床结局。这些发现支持将SSRF特别是早期进行SSRF作为功能依赖患者肋骨骨折治疗的有益策略。即使在后期进行,SSRF在降低死亡率方面仍优于保守治疗。有必要进行前瞻性研究以验证这些结果并建立明确的患者选择标准。